What is a lack of myostatin?

myostatin deficit concerns the abnormal state of growth in which mystatin, protein responsible for muscle growth, is either missing or deactivated. Without the fully functioning of myostatin proteins in the body, muscles can grow freely without restrictions. This leads to the state of muscle hypertrophy in which the muscles of the body grow to an abnormal size. Each cell in the body has two instances of this gene. One mutation is used in one case the gene may cause a lack of myostatin by disruption by the way the body produces or uses myostatin. If both instances of the gene gene are mutated in each cell, then muscle hypertrophy is usually more serious.

Mutation in the MTN gene can lead to lack of mysstatin in one of two ways. In some cases, the instructions concerning the production of myostatin will be equally mutated, the cell leaders in the body to either produce small or no myostin at all. Other times, the instructions concerning the correct use of myostatin are damaged. In this case it may be in the cellularA lots of myostatin proteins are available, but they just fit idle because they are not ordered to do anything.

In 2010, there was no clinical treatment of myostatin deficiency. Case studies of animals such as mice and cattle have revealed that the growth of the muscles resulting from the lack of myostatin never exceeds 40 percent. Myostatin works as in humans as in animals, so the lack of myostatin is not fatal. Only a very minute part of the popular suffer from a lack of myostatin. This includes children and several selected professional bodybuilders.

Although the lack of myostatin is an undesirable condition in itself, they hope to cure muscle dystrophy for one day for one day. By injection into body substances that block myostatin, he hopes that the weakened muscles of muscle dystrophy will grow to their normal size. However, there is concern that such a solution could inevitably be in the futureto render the worsening of the disease.

At the same time, the idea of ​​using myostatin blockers to promote muscle growth in bodybuilders was also considered. However, any such option would require intensive FDA testing before release to the mainstream market. It could also face the regulation of government bodies of the competitive bodybuilding industry.